Xenetic Biosciences (XBIO) Earnings Date & Reports

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

XBIO is expected to report earnings to fall 83.82% to -10 cents per share on May 17

Xenetic Biosciences XBIO Stock Earnings Reports

Q1'23

Est.

$-0.11

Q4'24

Missed

by $0.51

Q4'22

Est.

$-0.10

Q3'22

Est.

$-0.06

Q2'22

Est.

$-0.19

The last earnings report on March 18 showed earnings per share of -68 cents, missing the estimate of -17 cents. With 0.00 shares outstanding, the current market capitalization sits at 4.16M.

View a ticker or compare two or three

Compare

XBIO